62nd ASH Annual Meeting and Exposition

Wednesday, December 2, 2020

6:00 AM-11:55 PM

Brain Break: The Georgia Aquarium Welcomes Furry Guests!

ASH Wellness Studio

7:00 AM-7:05 AM

Scientific Workshop on Infectious Disease and Coagulation - Opening Remarks

Scientific Workshops @ ASH

Scientific Workshop on Tumor Immune Interactions in Lymphoid Malignancies - Opening Remarks

Scientific Workshops @ ASH

Scientific Workshop on Myeloid Development - Opening Remarks

Scientific Workshops @ ASH

7:05 AM-7:45 AM

Stem Cells

Scientific Workshops @ ASH

7:05 AM-8:20 AM

Immune Engaging Molecules in the Management of Lymphoid Malignancies

Scientific Workshops @ ASH

7:05 AM-8:30 AM

The Immunohemostatic Response to Infection

Scientific Workshops @ ASH

7:45 AM-8:25 AM

Hematologic Malignancies

Scientific Workshops @ ASH

8:20 AM-9:55 AM

Engineered Immune Cells in the Management of Lymphoid Malignancies

Scientific Workshops @ ASH

8:35 AM-9:15 AM

Transcription Factors and Epigenetics

Scientific Workshops @ ASH

8:35 AM-9:35 AM

Prevention and Monitoring

Scientific Workshops @ ASH

9:15 AM-9:55 AM

Signaling and Development

Scientific Workshops @ ASH

9:35 AM-9:50 AM

Full Panel Discussion

Scientific Workshops @ ASH

9:50 AM-10:00 AM

Scientific Workshop on Infectious Disease and Coagulation - Closing Remarks

Scientific Workshops @ ASH

9:55 AM-10:00 AM

Scientific Workshop on Tumor Immune Interactions in Lymphoid Malignancies - Closing Remarks

Scientific Workshops @ ASH

Scientific Workshop on Myeloid Development - Closing Remarks

Scientific Workshops @ ASH

Thursday, December 3, 2020

7:00 AM-7:02 AM

Scientific Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma - Opening Remarks

Scientific Workshops @ ASH

7:00 AM-7:05 AM

Scientific Workshop on Interplay Between Coagulation and Malignancy - Opening Remarks

Scientific Workshops @ ASH

7:00 AM-7:10 AM

ASH Talks

Welcome Video and Opening Song

ASH-a-Palooza

7:02 AM-7:42 AM

Integrating MRD into Clinical Trial Design and Clinical Practice

Scientific Workshops @ ASH

7:05 AM-7:29 AM

MicroRNA and Role in Cancer Associated Thrombosis

Scientific Workshops @ ASH

7:15 AM-7:55 AM

Blood Drops

Blood Drop: ASH Clinical Research Training Institute (CRTI)

ASH-a-Palooza

Blood Drops

Blood Drop: ASH Medical Educators Institute (ASH MEI)

ASH-a-Palooza

Blood Drops

Blood Drop: ASH Minority Medical Student Award Program (MMSAP)

ASH-a-Palooza

Blood Drops

Blood Drop: Health Disparities

ASH-a-Palooza

Blood Drops

Blood Drop: HONORS

ASH-a-Palooza

Blood Drops

Blood Drop: PhD

ASH-a-Palooza

Blood Drops

Blood Drop: Sickle Cell Disease

ASH-a-Palooza

Blood Drops

Blood Drop: Special Interest

ASH-a-Palooza

7:29 AM-8:17 AM

Interplay Between the Hematologic System and Solid Tumor Progression

Scientific Workshops @ ASH

7:42 AM-8:22 AM

The Molecular and Immunobiology of Disease Evolution and Progression in Multiple Myeloma

Scientific Workshops @ ASH

8:00 AM-8:40 AM

ASH Talks

ASH Talk 1: Leadership

ASH-a-Palooza

8:17 AM-8:55 AM

Modeling Predictors and Outcomes in Myeloproliferative Neoplasms and Thrombosis

Scientific Workshops @ ASH

8:32 AM-9:12 AM

Adaption of Next Generation Sequencing, Next Generation Flow Cytometry, and CyTOF: Diverse Ways of Detection

Scientific Workshops @ ASH

8:45 AM-9:25 AM

Blood Drops

Blood Drop: ASH Clinical Research Training Institute (CRTI)

ASH-a-Palooza

Blood Drops

Blood Drop: ASH Medical Educators Institute (ASH MEI)

ASH-a-Palooza

Blood Drops

Blood Drop: ASH Minority Medical Student Award Program (MMSAP)

ASH-a-Palooza

Blood Drops

Blood Drop: Health Disparities

ASH-a-Palooza

Blood Drops

Blood Drop: HONORS

ASH-a-Palooza

Blood Drops

Blood Drop: PhD

ASH-a-Palooza

Blood Drops

Blood Drop: Sickle Cell Disease

ASH-a-Palooza

Blood Drops

Blood Drop: Special Interest

ASH-a-Palooza

8:55 AM-9:56 AM

Late-Breaking Research Presentations

Scientific Workshops @ ASH

9:12 AM-9:57 AM

CAR-T and Other Cellular Therapy for Mutiple Myeloma

Scientific Workshops @ ASH

9:30 AM-11:00 AM

Special Symposium on Quality: Blood, Debt and Tears: Tackling Burnout in Hematology

Special-Interest Sessions

9:56 AM-10:00 AM

Scientific Workshop on Interplay Between Coagulation and Malignancy - Closing Remarks

Scientific Workshops @ ASH

9:57 AM-10:00 AM

Scientific Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma - Closing Remarks

Scientific Workshops @ ASH

10:00 AM-12:00 PM

ASH-a-Palooza

Blood Buddies: Adult Clinical Malignant Hematology

ASH-a-Palooza

Blood Buddies: Adult Clinical Malignant Hematology

ASH-a-Palooza

Blood Buddies: Adult Clinical Non-Malignant Hematology

ASH-a-Palooza

Blood Buddies: Adult Clinical Non-Malignant Hematology

ASH-a-Palooza

Blood Buddies: Adult Clinical Non-Malignant Hematology

ASH-a-Palooza

Blood Buddies: Lab & Translational Hematology

ASH-a-Palooza

Blood Buddies: Lab & Translational Hematology

ASH-a-Palooza

Blood Buddies: Lab & Translational Hematology

ASH-a-Palooza

Blood Buddies: Pediatric and Adult BMT

ASH-a-Palooza

Blood Buddies: Pediatric and Adult BMT

ASH-a-Palooza

Blood Buddies: Pediatric Clinical Malignant Hematology

ASH-a-Palooza

Blood Buddies: Pediatric Clinical Malignant Hematology

ASH-a-Palooza

Blood Buddies: Pediatric Clinical Malignant Hematology

ASH-a-Palooza

Blood Buddies: Pediatric Clinical Non-Malignant Hematology

ASH-a-Palooza

Blood Buddies: Pediatric Clinical Non-Malignant Hematology

ASH-a-Palooza

Blood Buddies: PhD Careers

ASH-a-Palooza

Blood Buddies: PhD Careers

ASH-a-Palooza

Blood Buddies: Quality Improvement

ASH-a-Palooza

Blood Buddies: Quality Improvement

ASH-a-Palooza

Blood Buddy Forum

Blood Buddy Forum: Adult and Pediatric BMT

ASH-a-Palooza

Blood Buddy Forum

Blood Buddy Forum: Adult Clinical Malignant Hematology

ASH-a-Palooza

Blood Buddy Forum

Blood Buddy Forum: Adult Clinical Non-Malignant Hematology

ASH-a-Palooza

Blood Buddy Forum

Blood Buddy Forum: Clinical Careers in Hematology (Private Practice)

ASH-a-Palooza

Blood Buddy Forum

Blood Buddy Forum: Government Careers (NIH and FDA)

ASH-a-Palooza

Blood Buddy Forum

Blood Buddy Forum: Industry Careers

ASH-a-Palooza

Blood Buddy Forum

Blood Buddy Forum: Laboratory and Translational Hematology

ASH-a-Palooza

Blood Buddy Forum

Blood Buddy Forum: Pediatric Clinical Malignant Hematology

ASH-a-Palooza

Blood Buddy Forum

Blood Buddy Forum: Pediatric Clinical Non-Malignant Hematology

ASH-a-Palooza

Blood Buddy Forum

Blood Buddy Forum: PhD Careers

ASH-a-Palooza

Blood Buddy Forum

Blood Buddy Forum: Systems Based Hematology

ASH-a-Palooza

2:00 PM-2:02 PM

Scientific Workshop on Hematology & Aging: Exploring Biomarkers, CHIP, CAR-T and Clotting - Opening Remarks

Scientific Workshops @ ASH

2:00 PM-2:05 PM

Scientific Workshop on Epidemiology: Disparities in Hematologic Diseases: Risk, Outcomes and Care - Opening Remarks

Scientific Workshops @ ASH

Scientific Workshop on Translational Molecular Diagnostics in Hematology - Opening Remarks

Scientific Workshops @ ASH

2:02 PM-2:45 PM

Thrombosis + Aging

Scientific Workshops @ ASH

2:05 PM-2:45 PM

Overcoming Challenges in Delivering Diagnostic Genomics in Hematology

Scientific Workshops @ ASH

2:05 PM-3:30 PM

Disparities in Malignant Hematology

Scientific Workshops @ ASH

2:45 PM-3:17 PM

CAR-T

Scientific Workshops @ ASH

2:45 PM-3:20 PM

Novel Diagnostic Genomic Tools and Technologies

Scientific Workshops @ ASH

3:22 PM-4:05 PM

Biomarkers of Aging

Scientific Workshops @ ASH

3:30 PM-4:25 PM

Variant Curation: How Should We Interpret What We Find?

Scientific Workshops @ ASH

3:30 PM-4:30 PM

Disparities in Benign Hematology

Scientific Workshops @ ASH

4:05 PM-4:58 PM

CHIPing Away at the Hematopoietic Stem Cell Niche

Scientific Workshops @ ASH

4:25 PM-4:55 PM

Molecular Tumor Board

Scientific Workshops @ ASH

4:30 PM-4:35 PM

Scientific Workshop on Epidemiology: Disparities in Hematologic Diseases: Risk, Outcomes and Care - Closing Remarks

Scientific Workshops @ ASH

4:55 PM-5:00 PM

Scientific Workshop on Translational Molecular Diagnostics in Hematology - Closing Remarks

Scientific Workshops @ ASH

4:58 PM-5:00 PM

Scientific Workshop on Hematology & Aging: Exploring Biomarkers, CHIP, CAR-T and Clotting - Closing Remarks

Scientific Workshops @ ASH

Friday, December 4, 2020

7:00 AM-7:05 AM

Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure - Opening Remarks

Scientific Workshops @ ASH

Scientific Workshop on Hematology and Pregnancy - Opening Remarks

Scientific Workshops @ ASH

Scientific Workshop on What ‘Omics Are Telling Us About Molecular Mechanisms in Sickle Cell Disease - Opening Remarks

Scientific Workshops @ ASH

7:00 AM-10:00 AM

Consensus or Controversy? Investigators Discuss Clinical Practice Patterns and Available Research Data Guiding the Management of Patients with Multiple Myeloma (Part 1 of a 4-Part Series)

Satellite Symposia

Mastering the Treatment of Myeloid Malignancies in the Era of Personalized Medicine

Satellite Symposia

7:05 AM-7:52 AM

Germline Predisposition Syndrome Modeling

Scientific Workshops @ ASH

7:05 AM-8:05 AM

Thrombosis and Bleeding in Pregnancy

Scientific Workshops @ ASH

7:05 AM-8:10 AM

Omics Approaches to Erythrocyte Biology in Sickle Cell Disease

Scientific Workshops @ ASH

7:15 AM-7:55 AM

Blood Drops

Blood Drop: ASH and EHA Translational Research Training in Hematology (TRTH)

ASH-a-Palooza

Blood Drops

Blood Drop: ASH & Harold Amos Medical Faculty Development Program (ASH-AMFDP)

ASH-a-Palooza

Blood Drops

Blood Drop: ASH Research Training Award for Fellows (ASH RTAF)

ASH-a-Palooza

Blood Drops

Blood Drop: ASH Scholar Award

ASH-a-Palooza

Blood Drops

Blood Drop: Finding Your Career

ASH-a-Palooza

Blood Drops

Blood Drop: Hemostasis and Thrombosis

ASH-a-Palooza

Blood Drops

Blood Drop: Quality Improvement

ASH-a-Palooza

Blood Drops

Blood Drop: Wellness

ASH-a-Palooza

7:52 AM-8:32 AM

SAMD9/SAMD9L Syndrome: Clinical and Biological Aspects

Scientific Workshops @ ASH

8:00 AM-8:40 AM

ASH Talks

ASH Talk 2: Racial Disparities in Healthcare

ASH-a-Palooza

8:05 AM-8:50 AM

Interplay of Pregnancy and Sickle Cell Disease

Scientific Workshops @ ASH

8:15 AM-9:05 AM

Exploring the ‘Omics of Cardiovascular and Renal Sequelae of Sickle Cell Disease

Scientific Workshops @ ASH

8:32 AM-9:05 AM

Socioeconomic Considerations and Quality of Life Issues in Patients with Germline Predisposition

Scientific Workshops @ ASH

8:45 AM-9:25 AM

Blood Drops

Blood Drop: ASH and EHA Translational Research Training in Hematology (TRTH)

ASH-a-Palooza

Blood Drops

Blood Drop: ASH & Harold Amos Medical Faculty Development Program (ASH-AMFDP)

ASH-a-Palooza

Blood Drops

Blood Drop: ASH Research Training Award for Fellows (ASH RTAF)

ASH-a-Palooza

Blood Drops

Blood Drop: ASH Scholar Award

ASH-a-Palooza

Blood Drops

Blood Drop: Finding Your Career

ASH-a-Palooza

Blood Drops

Blood Drop: Hemostasis and Thrombosis

ASH-a-Palooza

Blood Drops

Blood Drop: Quality Improvement

ASH-a-Palooza

Blood Drops

Blood Drop: Wellness

ASH-a-Palooza

8:45 AM-9:45 AM

Trainee Didactic Sessions

Trainee Didactic Session: Academic and Industry Career Pathway

ASH-a-Palooza

Trainee Didactic Sessions

Trainee Didactic Session: How to Transition from a Trainee to Faculty

ASH-a-Palooza

Trainee Didactic Sessions

Trainee Didactic Session: Intermediate Funding

ASH-a-Palooza

Trainee Didactic Sessions

Trainee Didactic Session: Quality Improvement, Quality Research in Hematology

ASH-a-Palooza

8:50 AM-9:50 AM

Complement Activation and Thrombotic Microangiopathies in Pregnancy

Scientific Workshops @ ASH

9:05 AM-9:52 AM

New Insights Into Germline Predisposition

Scientific Workshops @ ASH

9:10 AM-9:55 AM

Mechanistic Insights into Neurological Disease and Pain

Scientific Workshops @ ASH

9:50 AM-10:00 AM

Scientific Workshop on Hematology and Pregnancy - Closing Remarks

Scientific Workshops @ ASH

9:52 AM-10:00 AM

Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure - Closing Remarks

Scientific Workshops @ ASH

9:55 AM-10:00 AM

Scientific Workshop on What ‘Omics Are Telling Us About Molecular Mechanisms in Sickle Cell Disease - Closing Remarks

Scientific Workshops @ ASH

10:00 AM-12:00 PM

ASH-a-Palooza

Blood Buddies: Adult Clinical Malignant Hematology

ASH-a-Palooza

Blood Buddies: Adult Clinical Malignant Hematology

ASH-a-Palooza

Blood Buddies: Adult Clinical Non-Malignant Hematology

ASH-a-Palooza

Blood Buddies: Adult Clinical Non-Malignant Hematology

ASH-a-Palooza

Blood Buddies: Lab & Translational Hematology

ASH-a-Palooza

Blood Buddies: Lab & Translational Hematology

ASH-a-Palooza

Blood Buddies: Lab & Translational Hematology

ASH-a-Palooza

Blood Buddies: Pediatric and Adult BMT

ASH-a-Palooza

Blood Buddies: Pediatric and Adult BMT

ASH-a-Palooza

Blood Buddies: Pediatric and Adult BMT

ASH-a-Palooza

Blood Buddies: Pediatric Clinical Malignant Hematology

ASH-a-Palooza

Blood Buddies: Pediatric Clinical Malignant Hematology

ASH-a-Palooza

Blood Buddies: Pediatric Clinical Malignant Hematology

ASH-a-Palooza

Blood Buddies: Pediatric Clinical Non-Malignant Hematology

ASH-a-Palooza

Blood Buddies: PhD Careers

ASH-a-Palooza

Blood Buddies: PhD Careers

ASH-a-Palooza

Blood Buddies: PhD Careers

ASH-a-Palooza

Blood Buddies: Quality Improvement

ASH-a-Palooza

Blood Buddies: Quality Improvement

ASH-a-Palooza

Blood Buddy Forum

Blood Buddy Forum: Adult and Pediatric BMT

ASH-a-Palooza

Blood Buddy Forum

Blood Buddy Forum: Adult Clinical Malignant Hematology

ASH-a-Palooza

Blood Buddy Forum

Blood Buddy Forum: Adult Clinical Non-Malignant Hematology

ASH-a-Palooza

Blood Buddy Forum

Blood Buddy Forum: Clinical Careers in Hematology (Private Practice)

ASH-a-Palooza

Blood Buddy Forum

Blood Buddy Forum: Government Careers (NIH and FDA)

ASH-a-Palooza

Blood Buddy Forum

Blood Buddy Forum: Industry Careers

ASH-a-Palooza

Blood Buddy Forum

Blood Buddy Forum: Laboratory and Translational Hematology

ASH-a-Palooza

Blood Buddy Forum

Blood Buddy Forum: Medical Educators in Hematology

ASH-a-Palooza

Blood Buddy Forum

Blood Buddy Forum: Pediatric Clinical Malignant Hematology

ASH-a-Palooza

Blood Buddy Forum

Blood Buddy Forum: Pediatric Clinical Non-Malignant Hematology

ASH-a-Palooza

Blood Buddy Forum

Blood Buddy Forum: PhD Careers

ASH-a-Palooza

Blood Buddy Forum

Blood Buddy Forum: Systems Based Hematology

ASH-a-Palooza

11:00 AM-2:00 PM

Accelerating Toward a Cure for Myeloma: Emerging Data, New Agents, and an Evolving Treatment Paradigm

Satellite Symposia

Building New Management Models for NHL Care: Tumor Board Insights on Innovative Therapeutics in FL and DLBCL

Satellite Symposia

Consensus or Controversy? Investigators Discuss Clinical Practice Patterns and Available Research Data Guiding the Management of Patients with Chronic Lymphocytic Leukemia (Part 2 of a 4-Part Series)

Satellite Symposia

Advances in Therapy for Inherited Non-Malignant Blood Disorders: Focus on Sickle Cell Disease and Hemophilia.

Satellite Symposia

3:00 PM-6:00 PM

Adopting New Approaches for Relapsed/Refractory Follicular Lymphoma

Satellite Symposia

Applying Data to Practice: The Role of BTK Inhibitors for the Treatment of CLL

Satellite Symposia

Consensus or Controversy? Investigators Discuss Clinical Practice Patterns and Available Research Data Guiding the Management of Patients with Acute Myeloid Leukemia (Part 3 of a 4-Part Series)

Satellite Symposia

Evolving the Standard of Care: Rethinking the Treatment Paradigm for Iron Deficiency Anemia

Satellite Symposia

Experts Debate Optimal Approaches to the Treatment of Multiple Myeloma

Satellite Symposia

7:00 PM-10:00 PM

Consensus or Controversy? Investigators Discuss Clinical Practice Patterns and Available Research Data Guiding the Management of Patients with Hodgkin and Non-Hodgkin Lymphoma (Part 4 of a 4-Part Series)

Satellite Symposia

Improving Outcomes in MDS and MPN: Tailoring Treatment Based on Patient- and Disease-Specific Factors

Satellite Symposia

Saturday, December 5, 2020

6:30 AM-7:00 AM

Daily Zen: ASH Yoga

ASH Wellness Studio

7:00 AM-7:30 AM

Fireside Chat with Dr. Anthony Fauci

General Sessions

7:00 AM-3:30 PM

Visit the Industry Solutions Center (Exhibits and Other Learning)

Events

7:30 AM-8:15 AM

Advances in the Laboratory Assessment of Hemostatic and Thrombotic Disorders - Live Q&A

Education Program

A Map for the Changing Landscape of CLL - Live Q&A

Education Program

Extrinsic Regulation of Hematopoietic Stem Cell Emergence and Homeostasis - Live Q&A

Scientific Program

7:30 AM-9:00 AM

101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Mechanisms and Regulation of Erythropoiesis

Oral and Poster Abstracts

114. Hemoglobinopathies, Excluding Thalassemia—Clinical: Hydroxyurea for Sickle Cell Disease: Treatment Benefits and Potential Reproductive Risks for Women

Oral and Poster Abstracts

311. Disorders of Platelet Number or Function: Heparin-Induced Thrombocytopenia and Immune Thrombocytopenia

Oral and Poster Abstracts

616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel combination therapies in treatment of newly diagnosed AML

Oral and Poster Abstracts

617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Single Cell Profiling and Novel molecular Markers

Oral and Poster Abstracts

622. Lymphoma Biology—Non-Genetic Studies: Mechanisms of Lymphomagenesis, Progression, and Response

Oral and Poster Abstracts

624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: Clinical Studies in T/NK Cell Lymphoma

Oral and Poster Abstracts

632. Chronic Myeloid Leukemia: Therapy— Building The Future CML

Oral and Poster Abstracts

634. Myeloproliferative Syndromes: Clinical: New Therapies and JAKi-based Combinations for Myelofibrosis

Oral and Poster Abstracts

651. Myeloma: Biology and Pathophysiology, excluding Therapy: From Smoldering Myeloma to Active Myeloma: Innovative Early Detection Approaches, Epigenetic, Genomic and Transcriptome Scenarios.

Oral and Poster Abstracts

704. Immunotherapies: Beyond T to NK

Oral and Poster Abstracts

723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence I

Oral and Poster Abstracts

732. Clinical Allogeneic Transplantation: Results I

Oral and Poster Abstracts

8:15 AM-8:30 AM

Meditation: A Meditation on the Value of Heart - Brain Connection

ASH Wellness Studio

9:00 AM-9:30 AM

Daily Zen: ASH Tai Chi

ASH Wellness Studio

Learn from Industry by Visiting the Industry Solutions Center

Events

9:30 AM-10:15 AM

Challenges in Cell Therapy: Relapse and Toxicities - Live Q&A

Scientific Program

Diagnostic and Prognostic Models in VTE Management: Ready for Primetime? - Live Q&A

Education Program

Myelodysplastic Syndromes: What We Have and What We Want - Live Q&A

Education Program

Novel Blood Therapeutics - Live Q&A

Scientific Program

Single Cell Analysis of Hematopoietic Development and Clonal Complexity of Malignant Hematopoiesis - Live Q&A

Scientific Program

9:30 AM-11:00 AM

101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Mechanisms, Diagnosis and Treatment of Inherited

Oral and Poster Abstracts

113. Hemoglobinopathies, Excluding Thalassemia—New Genetic Approaches to Sickle Cell Disease: Fetal Hemoglobin Regulation And Reticulocyte Maturation In Sickle Cell Disease

Oral and Poster Abstracts

203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Pathogenesis and Immunotherapy

Oral and Poster Abstracts

401 Basic Science and Clinical Practice in Blood Transfusion: COVID-19 Convalescent Plasma, Antigen Typing and the Prothrombin Complex II

Oral and Poster Abstracts

602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Aberrant Nuclear Architecture and Chromatin Remodeling

Oral and Poster Abstracts

616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel promising therapies for relapsed/refractory AML

Oral and Poster Abstracts

623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies: Mantle Cell Lymphoma Clinical Trials

Oral and Poster Abstracts

642. CLL: Therapy, excluding Transplantation I

Oral and Poster Abstracts

653. Myeloma/Amyloidosis: Therapy, excluding Transplantation: CAR T Therapies for Myeloma: Novel Approaches and Longer-Term Follow Up Data

Oral and Poster Abstracts

721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities I

Oral and Poster Abstracts

731. Clinical Autologous Transplantation: Autologous Transplantation: Still the Backbone of Modern Myeloma Therapies

Oral and Poster Abstracts

904. Outcomes Research—Non-Malignant Conditions: Bleeding, Immune Thrombocytopenia, and Other Hematologic Disorders

Oral and Poster Abstracts

10:15 AM-10:30 AM

Optimizing Sleep to Prevent Burnout

ASH Wellness Studio

11:00 AM-12:00 PM

A Discussion of Efficacy and Safety on a Treatment Option for Adults With Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)

Product Theaters

Advances in the Treatment of aTTP

Product Theaters

A New Treatment Option for Patients with Acute Myeloid Leukemia

Product Theaters

Introducing BLENREP (belantamab mafodotin-blmf) for Injection, for Intravenous Use

Product Theaters

Learn from Industry by Visiting the Industry Solutions Center

Events

NGS Solutions That Help Simplify Your Journey to Answers in Hemato-Oncology Research

Product Theaters

Study Results from the First and Only Randomized Pivotal Trial in R/R DLBCL

Product Theaters

12:00 PM-12:15 PM

Massage Effects on the Nervous System

ASH Wellness Studio

12:00 PM-12:45 PM

Anxiety Provoking Hematology Consults, Second Edition - Live Q&A

Education Program

Appropriate Use of Imaging in Patients with Lymphoma - Live Q&A

Spotlight Sessions

Beyond the Marrow: Major Non-Hematologic Complications of Inherited Bone Marrow Failure Syndromes - Live Q&A

Education Program

Emicizumab’s Impact on the Landscape of Hemophilia A Treatment: Two Artists Debate the View - Live Q&A

Spotlight Sessions

Handling Challenging Questions in the Management of CML - Live Q&A

Education Program

RNA in Normal and Malignant Hematopoiesis - Live Q&A

Scientific Program

12:00 PM-1:30 PM

112. Thalassemia and Globin Gene Regulation

Oral and Poster Abstracts

614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Chimeric Antigen Receptor T Cell Therapy

Oral and Poster Abstracts

616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Advances in immunotherapeutics for management of AML

Oral and Poster Abstracts

625. Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents: Novel Approaches to Overcome Resistance

Oral and Poster Abstracts

653. Myeloma/Amyloidosis: Therapy, excluding Transplantation: Novel Therapies Targeting B Cell Maturation Antigen in Relapsed/Refractory Multiple Myeloma

Oral and Poster Abstracts

711. Cell Collection and Processing

Oral and Poster Abstracts

721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities II

Oral and Poster Abstracts

803. Emerging Diagnostic Tools and Techniques II

Oral and Poster Abstracts

904. Outcomes Research - Non-Malignant Conditions: Venous Thromboembolism Associated with Cancer and/or COVID-19

Oral and Poster Abstracts

905. Outcomes Research—Malignant Conditions (Lymphoid Disease): Outcomes Research Real World Data Healthcare Disparities

Oral and Poster Abstracts

906-Outcomes Research—Malignant Conditions (Myeloid Disease): Real World Management And Outcome

Oral and Poster Abstracts

Special Scientific Session on Race and Science

Special-Interest Sessions

12:30 PM-1:00 PM

Daily Zen: Sun Salutation - Australia

ASH Wellness Studio

1:30 PM-2:00 PM

Daily Zen: ASH Meditation

ASH Wellness Studio

Daily Zen: Sun Salutation - Japan

ASH Wellness Studio

Learn from Industry by Visiting the Industry Solutions Center

Events

2:00 PM-2:45 PM

Challenging Situations for Patients with Aggressive Lymphomas - Live Q&A

Education Program

Managing Toxicities of Targeted Therapies in CLL - Live Q&A

Education Program

The Emerging Role of Targeted Therapies and Cell Therapy in Transplant - Live Q&A

Education Program

2:00 PM-3:00 PM

Ham-Wasserman Lecture

General Sessions

2:00 PM-3:30 PM

102. Regulation of Iron Metabolism

Oral and Poster Abstracts

113. Hemoglobinopathies, Excluding Thalassemia—New Genetic Approaches to Sickle Cell Disease: New Insights Into Sickle Cell Disease Pathophysiology

Oral and Poster Abstracts

322. Disorders of Coagulation or Fibrinolysis: Hemophilia: Genes, Joints, and PK

Oral and Poster Abstracts

332. Anticoagulation and Antithrombotic Therapy: Novel Agents, Reversal Drugs and Indications

Oral and Poster Abstracts

401 Basic Science and Clinical Practice in Blood Transfusion: COVID-19 Convalescent Plasma and Transfusion Immunology I

Oral and Poster Abstracts

501. Hematopoietic Stem and Progenitor Biology: New Insights into the Molecular Regulation of Hematopoietic Stem Cells

Oral and Poster Abstracts

508. Bone Marrow Failure: Advancing Our Biologic Understanding in Inherited and Acquired Bone Marrow Failure Disorders

Oral and Poster Abstracts

604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Oral and Poster Abstracts

612. Acute Lymphoblastic Leukemia: Clinical Studies: Innovative Chemotherapy and Immunotherapy Strategies in Frontline and Relapsed Disease

Oral and Poster Abstracts

617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: MRD and Novel molecular Markers

Oral and Poster Abstracts

621. Lymphoma—Genetic/Epigenetic Biology: Genetic and epigenetic profiling of malignant lymphomas

Oral and Poster Abstracts

636. Myelodysplastic Syndromes—Basic and Translational Studies

Oral and Poster Abstracts

653. Myeloma/Amyloidosis: Therapy, excluding Transplantation: Bispecific T Cell Engager Therapies and Novel Targeting Agents

Oral and Poster Abstracts

732. Clinical Allogeneic Transplantation Results III

Oral and Poster Abstracts

901. Health Services Research—Non-Malignant Conditions I

Oral and Poster Abstracts

902. Health Services Research—Malignant Conditions (Lymphoid Disease) I

Oral and Poster Abstracts

2:30 PM-3:00 PM

Daily Zen: Sun Salutation - China

ASH Wellness Studio

2:45 PM-3:00 PM

Why Manage Stress When You Can Fully Prevent It?

ASH Wellness Studio

3:30 PM-4:30 PM

ASH Awards Presentation

General Sessions

9:30 PM-10:00 PM

Daily Zen: Sun Salutation - Central Europe

ASH Wellness Studio

10:30 PM-11:00 PM

Daily Zen: Sun Salutation - United Kingdom

ASH Wellness Studio

Sunday, December 6, 2020

1:30 AM-2:00 AM

Daily Zen: Sun Salutation - Argentina

ASH Wellness Studio

2:30 AM-3:00 AM

Daily Zen: Sun Salutation - Brazil

ASH Wellness Studio

6:30 AM-7:00 AM

Daily Zen: Sun Salutation - North America

ASH Wellness Studio

7:00 AM-9:00 AM

Plenary Scientific Session

General Sessions

7:00 AM-3:30 PM

Visit the Industry Solutions Center (Exhibits and Other Learning)

Events

8:00 AM-8:15 AM

Yoga: A Yogic Practice for Longevity and Preventing Cognitive Decline

ASH Wellness Studio

9:00 AM-9:30 AM

Daily Zen: ASH Tai Chi

ASH Wellness Studio

Learn from Industry by Visiting the Industry Solutions Center

Events

9:30 AM-10:15 AM

Friend or Foe: The Microbiome, Antibiotics and Death After Transplant - Live Q&A

Special Scientific Symposia

Immunotherapy in Multiple Myeloma - Live Q&A

Education Program

Location, Location, Location - Live Q&A

Scientific Program

Platelet Transfusions for Hematology / Oncology Patients: Taking a More Granular Look - Live Q&A

Education Program

9:30 AM-10:30 AM

ASH-EHA Joint Symposium: Failure of Targeted Cellular Immunotherapy and Hematopoietic Cell Transplant: Mechanisms and Mitigating Strategies

General Sessions

9:30 AM-11:00 AM

203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Hematologic Malignancies and COVID-19

Oral and Poster Abstracts

301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry

Oral and Poster Abstracts

502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Molecular regulation of cell fate and regeneration

Oral and Poster Abstracts

613. Acute Myeloid Leukemia: Novel Therapies and Treatment Approaches

Oral and Poster Abstracts

623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies: Clinical studies in Waldenstrom's Macroglobulinemia, Marginal Zone Lymphoma and Hairy Cell Leukemia

Oral and Poster Abstracts

634. Myeloproliferative Syndromes: Clinical: Translational Science in MPN— Hitting the Mark

Oral and Poster Abstracts

641. CLL: Biology and Pathophysiology, excluding Therapy: Treatment Resistance and Prognosis

Oral and Poster Abstracts

722. Clinical Allogeneic Transplantation: Acute and Chronic GvHD, Immune Reconstitution: Phase I and II Trials

Oral and Poster Abstracts

803. Emerging Diagnostic Tools and Techniques I

Oral and Poster Abstracts

904. Outcomes Research - Non-Malignant Conditions: Sickle Cell Disease and Beta Thalassemia

Oral and Poster Abstracts

905. Outcomes Research—Malignant Conditions (Lymphoid Disease): Outcomes Research Real World Data Lymphoma

Oral and Poster Abstracts

The 2020 Pandemic: Latest Insights on COVID-19

Special-Interest Sessions

10:15 AM-10:30 AM

Food Mistakes That Might Be Contributing to Your Burnout

ASH Wellness Studio

11:00 AM-12:00 PM

An Anti-CD38 Directed Antibody for the Treatment for Appropriate Patients with Relapsed Refractory Multiple Myeloma

Product Theaters

A Targeted Therapeutic Approach for Relapsed or Refractory FLT3m+ AML Patients

Product Theaters

A Treatment Option for Adult Patients With Newly Diagnosed CP Ph+ CML or Patients With CML Resistant/Intolerant to Prior TKI Therapy

Product Theaters

A Treatment Option for Patients with Myelodysplastic Syndromes

Product Theaters

Developing the Future of CAR-T Cell Therapy Today

Product Theaters

Learn from Industry by Visiting the Industry Solutions Center

Events

MONJUVI (tafasitamab-cxix) For Use As Second-line Therapy in Adult Patients with R/R DLBCL, In Combination With Lenalidomide

Product Theaters

Redefining Approaches in Early-Line Multiple Myeloma Treatment

Product Theaters

12:00 PM-12:15 PM

The Benefits of Mindfulness Practice

ASH Wellness Studio

12:00 PM-12:45 PM

ASH Choosing Wisely® Campaign: 2020 ASH Choosing Wisely Champions - Live Q&A

Special-Interest Sessions

Cellular Breakups: Transfusion and Hyperhemolysis in Sickle Cell Disease - Live Q&A

Spotlight Sessions

Checkpoint Blockade: Defining A New Treatment Paradigm in Hodgkin Lymphoma and Allogeneic Transplantation - Live Q&A

Spotlight Sessions

Indolent Lymphomas: Answers to Smoldering Questions - Live Q&A

Education Program

Selected Hemostasis and Thrombosis Topics in Women - Live Q&A

Education Program

What the Children Can Teach Us: Congenital Immunodeficiencies Shed Light on Immunity, Hematopoiesis, and Cancer - Live Q&A

Scientific Program

12:00 PM-1:30 PM

311. Disorders of Platelet Number or Function: Thrombotic Thrombocytopenic Purpura and Platelet Dysfunction

Oral and Poster Abstracts

503. Clonal Hematopoiesis: Aging and Inflammation

Oral and Poster Abstracts

613. Acute Myeloid Leukemia: Molecular Mutations and Their Prognostic Implications

Oral and Poster Abstracts

618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis II

Oral and Poster Abstracts

626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials: Updates and advances in bispecific antibody therapies and autologous CAR-T approaches

Oral and Poster Abstracts

636. Myelodysplastic Syndromes — Basic and Translational Studies

Oral and Poster Abstracts

653. Myeloma/Amyloidosis: Therapy, excluding Transplantation: Relapsed/Refractory Multiple Myeloma

Oral and Poster Abstracts

722. Clinical Allogeneic Transplantation: Acute and Chronic GvHD, Immune Reconstitution: Pathobiology and Predictive Biomarkers

Oral and Poster Abstracts

901. Health Services Research—Non-Malignant Conditions II

Oral and Poster Abstracts

903. Health Services Research—Malignant Conditions (Myeloid Disease): Barriers to Cancer Care Delivery in Myeloid Malignancies

Oral and Poster Abstracts

905. Outcomes Research—Malignant Conditions (Lymphoid Disease): Outcomes Research Real World Data Myeloma

Oral and Poster Abstracts

1:30 PM-2:00 PM

Daily Zen: ASH Meditation

ASH Wellness Studio

Learn from Industry by Visiting the Industry Solutions Center

Events

2:00 PM-2:45 PM

Caring for Patients with Acute Leukemia in Community Hospitals: Who, What, and When to Refer? - Live Q&A

Education Program

Getting the Most from Minimal Residual Disease - Live Q&A

Scientific Program

Molecular Basis of Platelet/Megakaryocyte Dysfunction: Novel Approaches - Live Q&A

Scientific Program

Monoclonal Gammopathies of Determined Significance - Live Q&A

Education Program

Special Joint Education-Scientific Symposium: Hormones and Hematology - Live Q&A

Special Scientific Symposia

The Brain and Pain in Sickle Cell Disease: Understanding the Role of Sensory, Cognition and Neuropathic Pathways in the SCD Chronic Pain Experience - Live Q&A

Education Program

2:00 PM-3:30 PM

331. Pathophysiology of Thrombosis I

Oral and Poster Abstracts

506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells

Oral and Poster Abstracts

602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Altered Transcription Factor Regulation

Oral and Poster Abstracts

613. Acute Myeloid Leukemia: Potpourri of Potential Practice Changing Studies

Oral and Poster Abstracts

614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Targeted Therapies

Oral and Poster Abstracts

624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: Clinical Studies in Hodgkin Lymphoma

Oral and Poster Abstracts

627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: PCNSL Treatment and Prognosis and CNS Prophylaxis in High-Risk Aggressive Lymphomas

Oral and Poster Abstracts

634. Myeloproliferative Syndromes: Clinical: Clinical Trials in Polycythemia Vera

Oral and Poster Abstracts

651. Myeloma: Biology and Pathophysiology, excluding Therapy: The Role of the Bone Marrow Microenvironment in the Pathogenesis and Therapy of Multiple Myeloma and Waldenstrom’s Macroglobulinemia.

Oral and Poster Abstracts

723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence II

Oral and Poster Abstracts

801. Gene Editing, Therapy and Transfer I

Oral and Poster Abstracts

Blood & Beyond

Special-Interest Sessions

2:45 PM-3:00 PM

The Link Is What You Think: DALPO

ASH Wellness Studio

Monday, December 7, 2020

6:30 AM-7:00 AM

Daily Zen: ASH Yoga

ASH Wellness Studio

7:00 AM-7:45 AM

Acute Myeloid Leukemia - So Many Treatment Options; How Do You Decide? - Live Q&A

Education Program

Improving Symptom Control for Children with Hematological Malignancies - Live Q&A

Education Program

Infection Risk, Immunization Recommendations, and Antimicrobial Prophylaxis Needs when Treating Non-Malignant Hematologic Disorders - Wash Your Hands and What Else? - Live Q&A

Education Program

Understanding How to Manipulate the Immune System in Immunotherapy for Lymphoma - Live Q&A

Education Program

Vascular Anomalies 101: Case-Based Discussion on the Diagnosis, Treatment and Lifelong Care of These Patients - Live Q&A

Spotlight Sessions

What Hematologists Need to Know About Giving and Stopping Aspirin - Live Q&A

Education Program

7:00 AM-8:30 AM

114. Hemoglobinopathies, Excluding Thalassemia—Clinical: Assessment and Prevention of End-Organ Injury in Sickle Cell Disease

Oral and Poster Abstracts

322. Disorders of Coagulation or Fibrinolysis: Hemophilia: Treatment and Inhibitors

Oral and Poster Abstracts

331. Pathophysiology of Thrombosis II

Oral and Poster Abstracts

603. Oncogenes and Tumor suppressors: Pre clinical models and Novel Targets

Oral and Poster Abstracts

605. Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases: Molecular pharmacology and drug resistance mechanisms in lymphoproliferative disorders

Oral and Poster Abstracts

627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: Biomarkers and Prognostication in Aggressive B-Cell Non-Hodgkin Lymphomas

Oral and Poster Abstracts

637. Myelodysplastic Syndromes—Clinical Studies: Personalized Clinical-Decision Tools and treatment of lower risk MDS

Oral and Poster Abstracts

642. CLL: Therapy, excluding Transplantation II

Oral and Poster Abstracts

653. Myeloma/Amyloidosis: Therapy, excluding Transplantation: Initial Therapy

Oral and Poster Abstracts

703. Adoptive Immunotherapy: Mechanisms and New Approaches: Optimizing CAR T cells for Improved Outcomes

Oral and Poster Abstracts

732. Clinical Allogeneic Transplantation Results II

Oral and Poster Abstracts

802. Chemical Biology and Experimental Therapeutics: Innovations in Therapy and Drug Screening

Oral and Poster Abstracts

7:00 AM-3:30 PM

Visit the Industry Solutions Center (Exhibits and Other Learning)

Events

7:45 AM-8:00 AM

Nutrition: Genetics Driven Nutraceuticals

ASH Wellness Studio

8:30 AM-9:00 AM

Daily Zen: ASH Tai Chi

ASH Wellness Studio

Learn from Industry by Visiting the Industry Solutions Center

Events

9:00 AM-9:45 AM

Gut Microbiome and the Endothelium - Live Q&A

Scientific Program

Hematopoietic Aging: Mechanisms and Consequences - Live Q&A

Scientific Program

How to Manage Common Challenging Situations in Patients with Multiple Myeloma - Live Q&A

Spotlight Sessions

Mechanisms and Modifiers of Bleeding - Live Q&A

Scientific Program

Myeloproliferative Disorders: Too Many Cells, Too Few Therapies - How Do We Choose? - Live Q&A

Education Program

Transfusion and Anemia in Global Health - Live Q&A

Spotlight Sessions

Updates on the Role of Non-Anticoagulant Interventions in Venous Thromboembolism - Live Q&A

Education Program

Yin and Yang of Autoimmunity and Immunodeficiencies in Hematology - Live Q&A

Education Program

9:00 AM-10:00 AM

Ernest Beutler Lecture and Prize

General Sessions

9:00 AM-10:30 AM

322. Disorders of Coagulation or Fibrinolysis: Von Willebrand Disease and Bleeding

Oral and Poster Abstracts

332. Anticoagulation and Antithrombotic Therapy: COVID-19, Obesity and Hemorrhagic Complications

Oral and Poster Abstracts

612. Acute Lymphoblastic Leukemia: Clinical Studies: Insights in Genomics, MRD, and Toxicities

Oral and Poster Abstracts

615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Commercially Available Therapy, excluding Transplantation I

Oral and Poster Abstracts

622. Lymphoma Biology—Non-Genetic Studies: Microenvironment and Immune Response in Hodgkin Lymphoma

Oral and Poster Abstracts

626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials: Incorporating novel agents and new adoptive cell therapy approaches

Oral and Poster Abstracts

651. Myeloma: Biology and Pathophysiology, excluding Therapy I

Oral and Poster Abstracts

703. Adoptive Immunotherapy: Mechanisms and New Approaches: Adoptive Cell Therapy beyond CAR T cells

Oral and Poster Abstracts

731. Clinical Autologous Transplantation: Building Better Transplant Platforms in Lymphoid Malignancies

Oral and Poster Abstracts

903. Health Services Research—Malignant Conditions (Myeloid Disease): Treatment and Publication Patterns in Myeloid Malignancies

Oral and Poster Abstracts

9:45 AM-10:00 AM

Exercise for Energy to Prevent Burnout

ASH Wellness Studio

10:30 AM-11:30 AM

clonoSEQ and MRD Assessment in the Management of Lymphoid Malignancies

Product Theaters

Exploring Outcomes With Fixed-Duration Treatment in CLL and New Evidence in First-Line AML: Pivotal Clinical Trial Data That Supports Treatment Decisions and Patient Care

Product Theaters

IMBRUVICA^® in Frontline CLL/SLL: A Case-based Approach

Product Theaters

Learn from Industry by Visiting the Industry Solutions Center

Events

PNH: Key Clinical Considerations for a Terminal Complement-Mediated Disease

Product Theaters

Scientific Exploration of Novel Targets for Hematology: A Glimpse into Areas of Research and Development

Product Theaters

Trust the Experience of a rFVIIa Product Used for a Wide Range of Indications

Product Theaters

11:30 AM-12:15 PM

Aggressive Lymphomas: What Novel Approaches Are Ready for Prime Time? - Live Q&A

Education Program

Chronic Transfusion Support: Challenging Cases - Live Q&A

Education Program

Junior Faculty Career Development Education Session - Live Q&A

Education Program

Pediatric Hematological Malignancies: CARs for Kids - Live Q&A

Education Program

Precision Medicine Approaches to Leukemia Predisposition in Bone Marrow Failure - Live Q&A

Scientific Program

The Immune System in Multiple Myeloma - Live Q&A

Scientific Program

Well-Regulated vs Malfunctioning Mechanisms of Iron Metabolism - Live Q&A

Scientific Program

11:30 AM-1:00 PM

321. Blood Coagulation and Fibrinolytic Factors: Coagulation and Fibrinolytic Factors: Regulation of Coagulation

Oral and Poster Abstracts

615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Commercially Available Therapy, excluding Transplantation II

Oral and Poster Abstracts

621. Lymphoma—Genetic/Epigenetic Biology: Clinical implications of biological insights in lymphoma

Oral and Poster Abstracts

624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: Immunotherapy in T/NK Cell Lymphoma

Oral and Poster Abstracts

632: Chronic Myeloid Leukemia: Therapy: CML: New and Beyond

Oral and Poster Abstracts

637. Myelodysplastic Syndromes—Clinical Studies: Treatment of Higher Risk Myelodysplastic syndromes

Oral and Poster Abstracts

641. CLL: Biology and Pathophysiology, excluding Therapy: Genetic Models and Genomic Landscape of CLL and Richter Transformation

Oral and Poster Abstracts

652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy

Oral and Poster Abstracts

801. Gene Editing, Therapy and Transfer II

Oral and Poster Abstracts

12:15 PM-12:30 PM

Earthing/Grounding

ASH Wellness Studio

1:00 PM-1:30 PM

Daily Zen: ASH Meditation

ASH Wellness Studio

Learn from Industry by Visiting the Industry Solutions Center

Events

1:30 PM-2:15 PM

Genetic Testing for Heritable Hematologic Disorders 101 - Live Q&A

Education Program

Out of Balance: Anemias Due to Disordered Iron Homeostasis - Live Q&A

Education Program

Special Symposium on the Basic Science of Hemostasis and Thrombosis - Live Q&A

Special Scientific Symposia

1:30 PM-2:30 PM

E. Donnall Thomas Lecture and Prize

General Sessions

1:30 PM-3:00 PM

114. Hemoglobinopathies, Excluding Thalassemia—Clinical:Novel Treatments for Sickle Cell Disease

Oral and Poster Abstracts

201. Granulocytes, Monocytes, and Macrophages

Oral and Poster Abstracts

617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Dissecting AML heterogeneity to refine treatment approaches

Oral and Poster Abstracts

618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis I

Oral and Poster Abstracts

623. Mantle Cell and Indolent B-Cell Lymphoma - CAR-T and immunotherapy clinical studies

Oral and Poster Abstracts

627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: Front-Line Treatment and Prognostication of Burkitt Lymphoma, Plasmablastic Lymphoma, and DLBCL

Oral and Poster Abstracts

631. CML: Biology and Pathophysiology, excluding Therapy: Mechanisms of Resistance and Progression in CML

Oral and Poster Abstracts

635. Myeloproliferative Syndromes: Basic Science

Oral and Poster Abstracts

651. Myeloma: Biology and Pathophysiology, excluding Therapy II

Oral and Poster Abstracts

653. Myeloma/Amyloidosis: Therapy, excluding Transplantation; Novel Approaches for Relapsed/Refractory Myeloma and Amyloidosis

Oral and Poster Abstracts

701. Experimental Transplantation: Basic Biology, Pre-Clinical Models

Oral and Poster Abstracts

704. Immunotherapies: Therapeutic T cell Manipulation

Oral and Poster Abstracts

902. Health Services Research—Malignant Conditions (Lymphoid Disease) II

Oral and Poster Abstracts

2:15 PM-2:30 PM

Compassion – The Patient Will See You Now

ASH Wellness Studio

Tuesday, December 8, 2020

6:30 AM-7:00 AM

Daily Zen: ASH Yoga

ASH Wellness Studio

7:00 AM-9:00 AM

Late-Breaking Abstracts Session

General Sessions

7:00 AM-3:00 PM

Visit the Industry Solutions Center (Exhibits and Other Learning)

Events

8:00 AM-8:15 AM

Stress Management: Gene Expression and Relaxation Response

ASH Wellness Studio

9:00 AM-9:15 AM

Blue Light and Burnout

ASH Wellness Studio

9:30 AM-11:00 AM

Presidential Symposium: Universal Donor Solutions in Hematology

General Sessions

11:00 AM-11:15 AM

The Mind-Body Connection

ASH Wellness Studio

11:15 AM-11:30 AM

Business Meeting

General Sessions

11:30 AM-1:00 PM

Modeling COVID-19: From the Lab to the World

Special-Interest Sessions

1:00 PM-1:30 PM

Daily Zen: ASH Tai Chi

ASH Wellness Studio

1:30 PM-3:00 PM

Best of ASH

General Sessions

2:00 PM-2:15 PM

Think Well To Burn Out The Burnout

ASH Wellness Studio

3:00 PM-3:30 PM

Daily Zen: ASH Meditation

ASH Wellness Studio

Wednesday, December 9, 2020

7:00 AM-8:00 AM

ASH Poster Walk on Current Challenges in Treating Hematologic Malignancies: Live Q&A

ASH Poster Walks

ASH Poster Walk on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure: Live Q&A

ASH Poster Walks

8:00 AM-9:00 AM

AstraZeneca's Focus on B-Cell Malignancy Posters

Company Focus on Disease Posters

10:00 AM-11:00 AM

Janssen Scientific Affairs, LLC’s Focus on B-Cell Malignancies Posters

Company Focus on Disease Posters

Thursday, December 10, 2020

7:00 AM-8:00 AM

ASH Poster Walk on Blood & Bone: From Hematopoiesis to Hemostasis: Live Q&A

ASH Poster Walks

ASH Poster Walk on Clinical Trials in Progress: Live Q&A

ASH Poster Walks

ASH Poster Walk on Exploring Quality Improvement: Live Q&A

ASH Poster Walks

ASH Poster Walk on Hematology and Aging: Live Q&A

ASH Poster Walks

ASH Poster Walk on Immunotherapies: A Walk Down Immunotherapy Lane: Watch Out for the CARs: Live Q&A

ASH Poster Walks

ASH Poster Walk on Novel Diagnostics and Treatments for Sickle Cell Disease: A New Era: Live Q&A

ASH Poster Walks

2:00 PM-3:00 PM

ASH Poster Walk on Healthcare Equity Matters: Live Q&A

ASH Poster Walks

ASH Poster Walk on Hemostasis and Thrombosis: Live Q&A

ASH Poster Walks